MaxCyte Signs Strategic Platform License with Lyell Immunopharma
Go back to MaxCyte Signs Strategic Platform License with Lyell Immunopharma| (NASDAQ: MXCT) | Delayed: 0.78 -0.06 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $ | |||
| Open | $0.84 | 52 Week Low | $ | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $ | |||
| Volume | 1,087,396 | |||||
| (NASDAQ: MXCT) | Delayed: 0.78 -0.06 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $ | |||
| Open | $0.84 | 52 Week Low | $ | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $ | |||
| Volume | 1,087,396 | |||||

